Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury

ER Burnside, F De Winter, A Didangelos, ND James… - Brain, 2018 - academic.oup.com
Chondroitinase ABC is a promising preclinical therapy that promotes functional
neuroplasticity after CNS injury by degrading extracellular matrix inhibitors. Efficient delivery …
被引用次数：115 相关文章
[PDF] core.ac.uk

[PDF][PDF] Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury

ER Burnside, F De Winter, A Didangelos, ND James… - Brain, 2018 - core.ac.uk
Spinal cord injury results in permanent disruption to nervous system function, for which there
is no current regenerative or pathology-modifying treatment (Ramer et al., 2014). Following …

Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury.

ER Burnside, F De Winter, A Didangelos… - Brain: a Journal of …, 2018 - europepmc.org
Chondroitinase ABC is a promising preclinical therapy that promotes functional
neuroplasticity after CNS injury by degrading extracellular matrix inhibitors. Efficient delivery …
[PDF] amazonaws.com

[PDF][PDF] Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury

ER Burnside, F De Winter, A Didangelos… - …, 2018 - pstorage-leicester-213265548798 …
Spinal cord injury results in permanent disruption to nervous system function, for which there
is no current regenerative or pathology-modifying treatment (Ramer et al., 2014). Following …
[PDF] researchgate.net

[PDF][PDF] Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury

ER Burnside, F De Winter, A Didangelos, ND James… - 2018 - researchgate.net
Spinal cord injury results in permanent disruption to nervous system function, for which there
is no current regenerative or pathology-modifying treatment (Ramer et al., 2014). Following …

Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury.

ER Burnside, F De Winter, A Didangelos, ND James… - 2018 - figshare.le.ac.uk
Chondroitinase ABC is a promising preclinical therapy that promotes functional
neuroplasticity after CNS injury by degrading extracellular matrix inhibitors. Efficient delivery …
[PDF] oup.com

[PDF][PDF] Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury

ER Burnside, F De Winter, A Didangelos, ND James… - Brain, 2018 - academic.oup.com
Chondroitinase ABC is a promising preclinical therapy that promotes functional
neuroplasticity after CNS injury by degrading extracellular matrix inhibitors. Efficient delivery …
[HTML] nih.gov

[HTML][HTML] Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury

ER Burnside, F De Winter, A Didangelos, ND James… - Brain, 2018 - ncbi.nlm.nih.gov
Chondroitinase ABC is a promising preclinical therapy that promotes functional
neuroplasticity after CNS injury by degrading extracellular matrix inhibitors. Efficient delivery …

Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury

ER Burnside, F De Winter… - Brain: a journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Chondroitinase ABC is a promising preclinical therapy that promotes functional
neuroplasticity after CNS injury by degrading extracellular matrix inhibitors. Efficient delivery …
[PDF] epfl.ch

[PDF][PDF] Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury

ER Burnside, F De Winter, A Didangelos, ND James… - Brain, 2018 - infoscience.epfl.ch
Spinal cord injury results in permanent disruption to nervous system function, for which there
is no current regenerative or pathology-modifying treatment (Ramer et al., 2014). Following …